← Leaderboards
Kathryn J Moore
Massachusetts General Hospital
$30,608,901
Attributed
$35,531,806
Total exposure
19
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$35,531,806 · 19
By mechanism
R01$20,147,967 · 10
P01$7,068,572 · 6
R35$6,715,541 · 1
RC1$997,106 · 1
R24$602,620 · 1
Top collaborators
- Joseph El-Khoury8 shared
- Edward A Fisher8 shared
- Katey Rayner4 shared
- Png Loke3 shared
Most similar at Massachusetts General Hospital
Same institution · by research overlap
- Cammie Lesser$16,591,943
- Seemantini K Nadkarni$9,725,963
- Bradley T Hyman$51,936,441
- Roy Soberman$7,702,299
- Nestor Uribe-Patarroyo$3,630,486
Others in their field
Top investigators on “Atherosclerosis”
- Eric A Boerwinkle · University Of Texas Hlth Sci Ctr Houston$63,519,256
- Josef Coresh · New York University School Of Medicine$60,445,875
- Daniel James Rader · University Of Pennsylvania$50,278,074
- Howard N Hodis · University Of Southern California$49,943,399
- Gary K Owens · University Of Virginia$42,472,259
- Alan Richard Tall · Columbia University Health Sciences$38,866,887
Research focus
AtherosclerosisPathway InteractionsInflammatoryCellsInflammationSignal TransductionMacrophageImmuneIn VivoMolecularInsightRegulationChronicInflammatory ResponseCholesterolTherapeutic TargetArterial Fatty StreakCytokineGene ExpressionReceptorSiteTissuesMediatingResponse
Grant awards (73)
The role of immune-responsive gene 1 and itaconate in atherosclerotic disease$757,945
R01 · FY2025 · HL · contact PI
Long noncoding RNA regulation of Atherosclerotic Cardiovascular Disease$731,843
R01 · FY2025 · HL · contact PI
Netrin-1 in Metabolic and Inflammatory Crosstalk in Cardiometabolic Disease$457,650
P01 · FY2025 · HL · contact PI
Pathology and Biochemistry Core$259,489
P01 · FY2025 · HL · contact PI
The role of immune-responsive gene 1 and itaconate in atherosclerotic disease$757,945
R01 · FY2024 · HL · contact PI
Long noncoding RNA regulation of Atherosclerotic Cardiovascular Disease$731,843
R01 · FY2024 · HL · contact PI
Netrin-1 in Metabolic and Inflammatory Crosstalk in Cardiometabolic Disease$507,097
P01 · FY2024 · HL · contact PI
Pathology and Biochemistry Core$267,346
P01 · FY2024 · HL · contact PI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis$1,017,000
R35 · FY2023 · HL · contact PI
Netrin-1 in Metabolic and Inflammatory Crosstalk in Cardiometabolic Disease$508,500
P01 · FY2023 · HL · contact PI
Pathology and Biochemistry Core$288,320
P01 · FY2023 · HL · contact PI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis$1,017,000
R35 · FY2022 · HL · contact PI
Netrin-1 in Metabolic and Inflammatory Crosstalk in Cardiometabolic Disease$508,500
P01 · FY2022 · HL · contact PI
Pathology and Biochemistry Core$288,320
P01 · FY2022 · HL · contact PI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis$1,017,000
R35 · FY2021 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of Guidance Cue Molecules$491,550
P01 · FY2021 · HL · contact PI
Core B: Biochemistry and Pathology$305,120
P01 · FY2021 · HL · contact PI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis$1,012,830
R35 · FY2020 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of Guidance Cue Molecules$491,550
P01 · FY2020 · HL · contact PI
Core B: Biochemistry and Pathology$305,120
P01 · FY2020 · HL · contact PI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis$998,631
R35 · FY2019 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2019 · HL
HDL and atherosclerosis regression$610,246
R01 · FY2019 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of Guidance Cue Molecules$491,550
P01 · FY2019 · HL · contact PI
Core B: Biochemistry and Pathology$305,120
P01 · FY2019 · HL · contact PI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis$829,905
R35 · FY2018 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2018 · HL
HDL and atherosclerosis regression$610,246
R01 · FY2018 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of Guidance Cue Molecules$491,550
P01 · FY2018 · HL · contact PI
miR-33 Pathway Inhibition for Improving HDL Functionality$469,834
R01 · FY2018 · HL · contact PI
Core B: Biochemistry and Pathology$305,120
P01 · FY2018 · HL · contact PI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis$823,175
R35 · FY2017 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2017 · HL
HDL and atherosclerosis regression$610,246
R01 · FY2017 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Adipose Tissue in High Fat Feeding: Role of Guidance Cue Molecules$491,550
P01 · FY2017 · HL · contact PI
miR-33 Pathway Inhibition for Improving HDL Functionality$469,834
R01 · FY2017 · HL · contact PI
Core B: Biochemistry and Pathology$305,120
P01 · FY2017 · HL · contact PI
Mechanisms of CD36 Signal Transduction - Resubmission - 1$206,112
R01 · FY2017 · HL · contact PI
Molecular Regulation of Atherosclerosis Regression$629,209
R01 · FY2016 · HL
HDL and atherosclerosis regression$610,246
R01 · FY2016 · HL · contact PI
miR-33 Pathway Inhibition for Improving HDL Functionality$469,834
R01 · FY2016 · HL · contact PI
Mechanisms of CD36 Signal Transduction - Resubmission - 1$423,750
R01 · FY2016 · HL · contact PI
Macrophage Trafficking, Inflammation & Metabolism in Obesity: Role of Guidance Cue Molecules$320,704
R01 · FY2016 · DK · contact PI
miR-33 Pathway Inhibition for Improving HDL Functionality$487,209
R01 · FY2015 · HL · contact PI
Mechanisms of CD36 Signal Transduction - Resubmission - 1$417,393
R01 · FY2015 · HL · contact PI
MicroRNAs as physiological and pathological regulators of cholesterol homeostasis$416,162
R01 · FY2015 · HL · contact PI
Mechanisms of CD36 Signal Transduction - Resubmission - 1$403,410
R01 · FY2014 · HL · contact PI
MicroRNAs as physiological and pathological regulators of cholesterol homeostasis$403,410
R01 · FY2014 · HL · contact PI
Mechanisms of CD36 Signal Transduction - Resubmission - 1$403,410
R01 · FY2013 · HL · contact PI
MicroRNAs as physiological and pathological regulators of cholesterol homeostasis$402,220
R01 · FY2013 · HL · contact PI
Toll-Like Receptor Signaling in Alzheimer's Disease$164,839
R01 · FY2013 · AG
MicroRNAs as physiological and pathological regulators of cholesterol homeostasis$422,500
R01 · FY2012 · HL · contact PI
Toll-Like Receptor Signaling in Alzheimer's Disease$327,259
R01 · FY2012 · AG
Toll-Like Receptor Signaling in Alzheimer's Disease$118,962
R01 · FY2012 · AG
MicroRNAs as physiological and pathological regulators of cholesterol homeostasis$422,500
R01 · FY2011 · HL · contact PI
Mechanisms of CD36 Signal Transduction$354,604
R01 · FY2011 · AG · contact PI
Toll-Like Receptor Signaling in Alzheimer's Disease$327,259
R01 · FY2011 · AG
Toll-Like Receptor Signaling in Alzheimer's Disease$539,021
R01 · FY2010 · AG
Immunomodulatory functions of neuronal guidance cues$498,342
RC1 · FY2010 · HL · contact PI
Mechanisms of CD36 Signal Transduction$368,919
R01 · FY2010 · AG · contact PI
Immunomodulatory functions of neuronal guidance cues$498,764
RC1 · FY2009 · HL · contact PI
Mechanisms of CD36 Signal Transduction$381,824
R01 · FY2009 · AG · contact PI
Toll-Like Receptor Signaling in Alzheimer's Disease$345,019
R01 · FY2009 · AG
Toll-Like Receptor Signaling in Alzheimer's Disease$196,512
R01 · FY2009 · AG
Mechanisms of CD36 Signal Transduction$381,824
R01 · FY2008 · AG · contact PI
Toll-Like Receptor Signaling in Alzheimer's Disease$343,199
R01 · FY2008 · AG · contact PI
Mechanisms of CD36 Signal Transduction$389,617
R01 · FY2007 · AG · contact PI
DEVELOPMENT AND CHARACTERIZATION OF CD14 DEFICIENT MICE$602,620
R24 · FY2005 · RR
Mechanisms in CD36 Signal Transduction$380,490
R01 · FY2005 · AG
Mechanisms in CD36 Signal Transduction$380,490
R01 · FY2004 · AG
Mechanisms in CD36 Signal Transduction$380,490
R01 · FY2003 · AG
Mechanisms in CD36 Signal Transduction$337,240
R01 · FY2002 · AG
Mechanisms in CD36 Signal Transduction$354,721
R01 · FY2001 · AG